EMA and African Medicines Agency Issue Joint Guidance for Ebola Vaccine Clinical Trials

The European Medicines Agency (EMA) and the African Medicines Agency (AMA) have collaborated to develop guidance for companies developing vaccines against the Bundibugyo virus (BDBV), a pathogen causing the current Ebola epidemic. This guidance aims to expedite clinical trials for BDBV vaccines amidst ongoing public health emergencies in several African nations.